5 Underperforming Stocks Targeted By Short Sellers

Page 1 of 5

In this article we discuss top 5 underperforming stocks targeted by short sellers. If you want to read our detailed analysis of the short-selling investing strategy and see some of the stocks with highest short interest, read 10 Underperforming Stocks Targeted By Short Sellers.

5. Akebia Therapeutics Inc (NASDAQ: AKBA)

Short % of Float (Jan 14, 2021): 22.93%

Short % of Shares Outstanding (Jan 14, 2021): 19.94%

Akebia is a Massachusetts-based company that is working to treat kidney disease complications. The company has a late stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), Vadadustat, for the treatment of anemia due to CKD.  Vadadustat has not been approved by the FDA or any other regulatory authority for use outside of Japan.

Akebia shares are down about 59% in the last 12 months. A total of 18 hedge funds in Insider Monkey database held stakes in Akebia as of the end of the third quarter, down from 25 funds a quarter earlier.

Page 1 of 5